Transgene SA (EPA: TNG)

Transgene Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	103	138	165	248	138	129
Market Cap Growth	-43.52%	-16.38%	-33.52%	79.73%	6.95%	-24.16%
Enterprise Value	124	124	138	218	134	166
Last Close Price	0.78	1.37	1.66	2.54	1.65	1.55
PS Ratio	12.12	17.44	15.93	14.38	14.41	9.70
PB Ratio	-168.38	8.82	4.35	3.69	2.72	1.96
P/TBV Ratio	-	8.87	4.36	3.69	2.73	1.97
EV/Sales Ratio	19.12	15.76	13.38	12.64	13.96	12.52
Debt / Equity Ratio	-59.71	1.11	0.36	0.25	0.36	0.44
Asset Turnover	0.13	0.14	0.12	0.18	0.10	0.12
Quick Ratio	1.40	1.69	2.38	4.17	2.11	2.52
Current Ratio	1.57	1.79	3.64	4.27	2.25	2.66
Return on Equity (ROE)	-214.69%	-83.54%	-62.45%	-33.13%	-29.60%	-36.73%
Return on Assets (ROA)	-38.85%	-33.60%	-22.21%	-15.81%	-15.14%	-14.16%
Return on Capital (ROIC)	-54.54%	-44.52%	-27.64%	-19.37%	-18.60%	-16.64%
Earnings Yield	-29.11%	-16.21%	-19.91%	-7.88%	-12.50%	-14.58%
FCF Yield	-37.80%	-27.10%	-13.23%	-10.72%	-21.43%	-18.69%
Buyback Yield / Dilution	-1.17%	-1.09%	-9.21%	-11.04%	-0.36%	-32.37%
Total Shareholder Return	-1.17%	-1.09%	-9.21%	-11.04%	-0.36%	-32.37%

Source: S&P Capital IQ. Standard template. Financial Sources.